Category: Post-Earnings
-
Netflix Stock Drops After Earnings Miss: Signal or Noise?
Netflix Inc. (NASDAQ: NFLX) reported its third-quarter earnings report after the market closed on October 21. The results left investors wanting to change the channel. Revenue of $11.51 billion met expectations. However, on the bottom line, the streaming giant reported earnings per share of $5.87, which was over 15% lower than the $6.97 that analysts expected. Predictably, NFLX stock is down sharply. As the market opens the…
-
RTX is Firing on All Cylinders; Short-Term Upside May Be Limited
RTX (NYSE: RTX) stock climbed 7.6% in the trading session after the company’s third-quarter earnings report. The aerospace and defense company delivered a strong report with a beat on the top and bottom lines, which was unexpected after the company warned of tariff impacts in its defense business. The company delivered $22.48 billion in revenue, which was 5.4% higher than…
-
Applied Digital: A Long-Term Buy That Continues to Build Momentum
Applied Digital continues to gain momentum after transforming into a compute-as-a-service company and securing $11 billion in long-term revenue from CoreWeave. With construction on key data centers progressing and shares up over 200% in three months, APLD offers investors a compelling long-term growth opportunity despite short-term volatility.
-
Will American Express Stock Charge Higher After Strong Earnings?
American Express Co. (NYSE: AXP) delivered a solid beat-and-raise earnings report before the market opened on October 17. If history is any guide, the report may not be enough to reverse the slide in AXP stock that started earlier in the week. But that could be a buying opportunity for opportunistic investors. American Express, or…
-
Buy PEP Stock Near Multi-Year Lows: Your Future Self Will Thank You
PepsiCo delivered better-than-expected Q3 earnings and raised its full-year outlook, sending shares modestly higher. While volume growth remains soft, the company’s focus on healthier snacks, portfolio streamlining, and value positioning suggest a turnaround is taking shape. With PEP stock near multi-year lows, long-term investors may find an attractive entry point.
-
JNJ Stock Slips Despite Beat and Raised Guidance
Johnson & Johnson delivered another solid quarter, beating expectations on both revenue and earnings while raising full-year guidance. However, the stock slipped in early trading as investors reacted to broader market weakness and an FDA warning for one of the company’s key oncology drugs, Carvykti. Despite the pullback, JNJ stock is up 32% in 2025…